These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. Brown TE J Child Adolesc Psychopharmacol; 2004; 14(1):129-36. PubMed ID: 15142400 [TBL] [Abstract][Full Text] [Related]
25. Cognitive effects of psychostimulant medication in hyperactive children. Everett J; Thomas J; Cote F; Levesque J; Michaud D Child Psychiatry Hum Dev; 1991; 22(2):79-87. PubMed ID: 1686856 [TBL] [Abstract][Full Text] [Related]
26. Monitoring psychostimulant side effects in hyperactive children. Golinko BE Drug Intell Clin Pharm; 1984 Apr; 18(4):324. PubMed ID: 6143650 [No Abstract] [Full Text] [Related]
27. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Aman MG; Binder C; Turgay A J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021 [TBL] [Abstract][Full Text] [Related]
28. Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder. Atmaca M; Ozler S; Topuz M; Goldstein S J Atten Disord; 2009 Sep; 13(2):197-8. PubMed ID: 19380515 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders]. Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180 [TBL] [Abstract][Full Text] [Related]
36. Recognition and treatment of attention deficit disorder. Bond WS Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464 [TBL] [Abstract][Full Text] [Related]
37. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study. Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383 [TBL] [Abstract][Full Text] [Related]
38. Drug therapy in the treatment of minimal brain dysfunction. Saccar CL Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219 [TBL] [Abstract][Full Text] [Related]
39. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. Hechtman L Psychopharmacol Bull; 1985; 21(2):178-91. PubMed ID: 2860690 [No Abstract] [Full Text] [Related]